Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Figlin

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Biological Response Modifiers|January 1, 1983
Effect of in vivo administration of interferon on human monocyte functionM Territo, G Sarna, R Figlin
Journal of Biological Response Modifiers|January 1, 1983
Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trialG Sarna, R Figlin, M Callaghan
Journal of Biological Response Modifiers|January 1, 1983
Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical resultsG Sarna, R Figlin, S McCarthy
Cancer|February 1, 1987
Interferon in renal cell carcinoma. The UCLA experienceG Sarna, R Figlin, J de Kernion
Seminars in Urologic Oncology|November 1, 1996
Renal cell carcinoma: basic biology and clinical behaviorJ R Franklin, R Figlin, A Belldegrun
Seminars in Urology|February 1, 1992
Immunotherapy for renal cell carcinomaA Belldegrun, R Figlin, J Danella, et al.
Chest|December 1, 1994
Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861R Figlin, E Mendoza, S Piantadosi, et al.
Cancer Treatment Reports|December 1, 1986
Phase I study of recombinant beta ser 17 interferon in the treatment of cancerG Sarna, M Pertcheck, R Figlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trialV W Rusch, R Figlin, D Godwin, et al.
Cancer Biotherapy|January 1, 1995
Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferonR P Whitehead, A Hauschild, E Christophers, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Biological Response Modifiers|January 1, 1983
Effect of in vivo administration of interferon on human monocyte functionM Territo, G Sarna, R Figlin
Journal of Biological Response Modifiers|January 1, 1983
Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trialG Sarna, R Figlin, M Callaghan
Journal of Biological Response Modifiers|January 1, 1983
Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical resultsG Sarna, R Figlin, S McCarthy
Cancer|February 1, 1987
Interferon in renal cell carcinoma. The UCLA experienceG Sarna, R Figlin, J de Kernion
Seminars in Urologic Oncology|November 1, 1996
Renal cell carcinoma: basic biology and clinical behaviorJ R Franklin, R Figlin, A Belldegrun
Seminars in Urology|February 1, 1992
Immunotherapy for renal cell carcinomaA Belldegrun, R Figlin, J Danella, et al.
Chest|December 1, 1994
Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861R Figlin, E Mendoza, S Piantadosi, et al.
Cancer Treatment Reports|December 1, 1986
Phase I study of recombinant beta ser 17 interferon in the treatment of cancerG Sarna, M Pertcheck, R Figlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trialV W Rusch, R Figlin, D Godwin, et al.
Cancer Biotherapy|January 1, 1995
Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferonR P Whitehead, A Hauschild, E Christophers, et al.
Pageof 5